https://pd173074inhibitor.com/....cadherin-17-precise-
The question of patient acceptance for intravitreal therapies intended to treat Geographic Atrophy (GA) remains unanswered. The study, accordingly, set out to examine the extent to which GA patients find regular intravitreal injections acceptable. To assess the acceptability of new GA treatments, thirty UK-based individuals with GA secondary to age-related macular degeneration (AMD), recruited from two London hospitals, participated in interviews spann
כמו
תגובה
לַחֲלוֹק
